EUVIMEDEUVIMED entdecken
Crossref

Finerenone in Patients with Focal Segmental Glomerulosclerosis

Hiddo J L Heerspink iD, Brendon L Neuen iD, Rajiv Agarwal iD, David Z I Cherney, Carolyn S P Lam iD, Katherine R Tuttle iD, Christoph Wanner iD, Pantelis Sarafidis iD, Glenn M Chertow iD, Tim Friede iD, Jonathan Barratt iD, Jürgen Floege und 19 weitere

Journal of the American Society of Nephrology · 15.11.2026

DOI: 10.1681/asn.0000001333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 15.11.2026. Verfasst von Hiddo J L Heerspink und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mineralocorticoid receptor overactivation is implicated in podocyte injury and glomerulosclerosis. In a prespecified analysis of the FIND-CKD trial, we examined the efficacy and safety of finerenone in participants with focal segmental glomerulosclerosis (FSGS).

Methods

The FIND-CKD trial randomized 1584 adults with nondiabetic CKD (eGFR ≥25 to

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • The George Institute for Global Health, University of New South Wales, Sydney, Australia.
  • Department of Renal Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Division of Nephrology, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana University School of Medicine, Indianapolis, USA.
  • Division of Nephrology, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
  • National Heart Centre Singapore, Singapore.

ORCID-Profile: Hiddo J L Heerspink, Brendon L Neuen, Rajiv Agarwal, Carolyn S P Lam, Katherine R Tuttle, Christoph Wanner, Pantelis Sarafidis, Glenn M Chertow, Tim Friede, Jonathan Barratt, Vladimir Dobronravov, Susanne B Nicholas, Hirokazu Okada, Marijn M Speeckaert, Niels Jongs, J David Smeijer, Carolina Aldworth, Mario Berger, Meike Brinker, Rania Dayoub, Marina Yael Finkelsztein, Aidan MacNamara, Patrick Schloemer

Zitieren

APA

Heerspink, H. J. L., Neuen, B. L., Agarwal, R., Cherney, D. Z. I., Lam, C. S. P., Tuttle, K. R., Wanner, C., Sarafidis, P., Chertow, G. M., Friede, T., Barratt, J., Floege, J., Chew-Wong, A., Dobronravov, V., Nicholas, S. B., Okada, H., Packham, D., Pergola, P. E., Speeckaert, M. M., …, & FIND-CKD Investigators (2026). Finerenone in Patients with Focal Segmental Glomerulosclerosis. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000001333

Vancouver

Heerspink HJL, Neuen BL, Agarwal R, Cherney DZI, Lam CSP, Tuttle KR, et al. Finerenone in Patients with Focal Segmental Glomerulosclerosis. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000001333

BibTeX
@article{Heerspink2026,
  author = {Heerspink, Hiddo J L and Neuen, Brendon L and Agarwal, Rajiv and Cherney, David Z I and Lam, Carolyn S P and Tuttle, Katherine R and Wanner, Christoph and Sarafidis, Pantelis and Chertow, Glenn M and Friede, Tim and Barratt, Jonathan and Floege, Jürgen and Chew-Wong, Alfredo and Dobronravov, Vladimir and Nicholas, Susanne B and Okada, Hirokazu and Packham, David and Pergola, Pablo E and Speeckaert, Marijn M and Tang, Shuifu and Jongs, Niels and Smeijer, J David and Aldworth, Carolina and Berger, Mario and Brinker, Meike and Dayoub, Rania and Finkelsztein, Marina Yael and MacNamara, Aidan and Schloemer, Patrick and Perkovic, Vlado and FIND-CKD Investigators, FIND-CKD Investigators},
  title = {Finerenone in Patients with Focal Segmental Glomerulosclerosis},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  doi = {10.1681/asn.0000001333}
}
Kostenlos starten →